MAPT Antikörper (AA 1-322) (HRP)
Kurzübersicht für MAPT Antikörper (AA 1-322) (HRP) (ABIN8010141)
Target
Alle MAPT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-322
-
Verwendungszweck
- Anti-Tau/MAPT Antibody HRP Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human Tau/MAPT recombinant protein (Position: M1-L322).
-
Isotyp
- IgG
-
-
anti-Microtubule-Associated Protein tau (MAPT) (AA 1-100) antibody
MAPT Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (AA 130-386) antibodyMAPT Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (AA 34-368) antibodyMAPT Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (pSer404) antibodyMAPT Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (pSer396) antibodyMAPT Reaktivität: Human WB, IHC Wirt: Kaninchen Monoclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (AA 92-400) antibodyMAPT Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (Ser404) antibodyMAPT Reaktivität: Human, Ratte, Maus, Rind (Kuh), Hund, Affe, Kaninchen, Ziege, Pferd WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (pSer262) antibodyMAPT Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (AA 33-166) antibodyMAPT Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Microtubule-Associated Protein tau (MAPT) (N-Term) antibodyMAPT Reaktivität: Human WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Andere Bezeichnung
- MAPT
-
Hintergrund
-
Background: MAPT, Microtubule-associated protein tau, appears to be enriched in axons. The MAPT gene is assigned to chromosome 17 by hybridization of a cDNA clone to flow-sorted and spot-blotted chromosomes and to 17q21 by in situ hybridization, containing 16 exons. The tau proteins are the product of alternative splicingfrom a single gene that in humans is designated MAPT. Tau proteins are proteins that stabilize microtubules. They are abundant in neurons in the central nervous system and are less common elsewhere. When tau proteins are defective, and no longer stabilize microtubules properly, they can result in dementias such as Alzheimer's disease.
Gene Full Name: microtubule associated protein tau
-
Gen-ID
- 4137
-
UniProt
- P10636
-
Pathways
- MAPK Signalweg, Microtubule Dynamics, M Phase, Regulation of Cell Size
Target
-
